Tilray Brands, Inc. - Common Stock (TLRY)

The cannabis stock has moved quickly in the past when there's been talk of marijuana reform.

The Tilray bull case is getting stronger without U.S. legalization.

Tilray Brands has moved beyond marijuana, turning itself into a diversified brand manager.

Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment?

Don't expect a rebound anytime soon.

The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now.

Recent results and legalization progress aren't the game changers you'd think they'd be for this cannabis stock.

After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.

The cannabis stock has struggled despite Tilray achieving solid growth in its most recent fiscal year.

The company's true organic growth is difficult to gauge given its high dependency on acquisitions.

Tilray's distribution segment was the only one that generated double-digit growth in its most recent fiscal year.

Tilray Brands shares jumped 2.23% after hours as quarterly revenue beat estimates, despite earnings per share missing expectations.

Tilray Brands (NASDAQ:TLRY) reported record fiscal 2026 revenue and adjusted EBITDA, supported by growth in international cannabis, pharmaceutical distribution, wellness and the fourth-quarter acquisition of BrewDog. For the fiscal year ended May 31, 2026, net revenue rose 11% to $915.5 million fro

Tilray will release its year-end numbers next week, which could have a significant impact on the stock.

The president directed federal authorities to reschedule medical marijuana.

The cannabis stock recently hit a new 52-week low.

A financial engineering move raised its ever-growing share count.

Tilray's future extends beyond one regulatory hearing.

There are much better ways to spend $5.

Tilray Brands tried one thing, and it didn't work; now it is trying another approach.

Investors seeking exposure to the marijuana market may now have a more attractive option to consider.

There are good things taking shape at Tilray, but there's one overriding theme that you can't ignore.

Trulieve's price has soared this year, while Tilray's has plummeted, but which is the better stock right now?

Most of Tilray's sales come from Canada and the European Union.

Tilray bought Brewdog on the cheap, but there's a reason why it got such a good price.